- Home
- PKBK vs INMB Comparison
PKBK vs INMB Comparison
Compare PKBK & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKBK
- INMB
- Stock Information
- Founded
- PKBK 1999
- INMB 2015
- Country
- PKBK United States
- INMB United States
- Employees
- PKBK N/A
- INMB N/A
- Industry
- PKBK Major Banks
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- PKBK Finance
- INMB Health Care
- Exchange
- PKBK Nasdaq
- INMB Nasdaq
- Market Cap
- PKBK 235.2M
- INMB 203.5M
- IPO Year
- PKBK N/A
- INMB 2019
- Fundamental
- Price
- PKBK $19.54
- INMB $8.59
- Analyst Decision
- PKBK
- INMB Strong Buy
- Analyst Count
- PKBK 0
- INMB 2
- Target Price
- PKBK N/A
- INMB $21.50
- AVG Volume (30 Days)
- PKBK 25.2K
- INMB 462.2K
- Earning Date
- PKBK 01-24-2025
- INMB 03-27-2025
- Dividend Yield
- PKBK 3.69%
- INMB N/A
- EPS Growth
- PKBK N/A
- INMB N/A
- EPS
- PKBK 2.27
- INMB N/A
- Revenue
- PKBK $62,281,000.00
- INMB $42,000.00
- Revenue This Year
- PKBK N/A
- INMB N/A
- Revenue Next Year
- PKBK N/A
- INMB N/A
- P/E Ratio
- PKBK $8.61
- INMB N/A
- Revenue Growth
- PKBK N/A
- INMB N/A
- 52 Week Low
- PKBK $15.24
- INMB $4.32
- 52 Week High
- PKBK $24.29
- INMB $13.52
- Technical
- Relative Strength Index (RSI)
- PKBK 42.26
- INMB 51.55
- Support Level
- PKBK $19.63
- INMB $8.90
- Resistance Level
- PKBK $20.18
- INMB $9.58
- Average True Range (ATR)
- PKBK 0.47
- INMB 0.93
- MACD
- PKBK 0.02
- INMB -0.20
- Stochastic Oscillator
- PKBK 22.64
- INMB 16.23
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.